We and others have shown that the expression of IL22RA2 is down-regulated during infectious colitis but not in IBD inflamed tissues, hence suggesting possible pathophysiological relevance for the IL-22BP-dependent modulation of IL-22 bioactivity (14, 15). This evidence concerns the gene IL22RA2 and inflammatory bowel disease.